Advocacy intelligence hub — real-time data for patient organizations
Sinovac Life Sciences Co., Ltd. — PHASE1
GlaxoSmithKline — PHASE3
University Ghent — PHASE4
CanSino Biologics Inc. — PHASE3
CanSino Biologics Inc. — PHASE4
CanSino Biologics Inc. — PHASE3
CanSino Biologics Inc. — PHASE3
CanSino Biologics Inc. — PHASE4
GlaxoSmithKline — PHASE2
Association Clinique Thérapeutique Infantile du val de Marne
Data from FDA regulatory filings and ClinicalTrials.gov. Updated periodically.
FINANCIAL LANDSCAPE SUMMARY
Total programs
Open now
Patient Assistance Programs1
Rifadin I.V.
Hoechst Marion Roussel
Baxter BioScience Investigator
Baxter Healthcare Corporation
Rebecca F Grais, PhD
Epicentre
Central Contact
Astellas Pharma Global Development
Wilbur Chen, MD, MS
Center for Vaccine Development and Global Health, University of Maryland School of Medicine
📍 BALTIMORE, MD
Nan Chang Chiu, Dr.
Mackay Memorial Hospital
Li Min Huang, Dr.
Dr. Li Min Huang, National Taiwan University Hospital